Revenue segments as reported by the company.

Premiums

Services

Investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefits

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Humana

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Humana exceeds earnings expectations, focuses on value-based care growth

Humana's strong financial performance and growth in value-based care position the company well for future success. Addressing audit error rates, uncertainties around RADV, and managing costs are key challenges. Opportunities in recruiting, revenue growth, and strategic partnerships offer avenues for further growth.

Humana exceeds Q1 expectations, eyes industry growth amidst challenges

Humana's strong Q1 performance and strategic decisions position it well for growth
Challenges like rate disruptions and Medicaid redeterminations require close monitoring
Opportunities in industry growth, member engagement, and benefit enhancements ahead
Commitment to long-term goals and high-quality service evident in company's outlook

Humana meets Q2 expectations, eyes growth in MA platform

Humana's Q2 performance met expectations with a focus on MA platform growth and disciplined investments.
Challenges include higher utilization in Medicare Advantage and broad-based medical cost trends.
Strategic benefits adjustments and competitive positioning present opportunities for growth and margin expansion.
Expectations for 2024 include maintaining market share, offsetting costs, and achieving strong membership growth.

Humana surpasses Q3 earnings expectations, eyes $37 EPS target

Humana's Q3 performance exceeded expectations, with strong membership growth and strategic initiatives driving future profitability.
While facing challenges in benefit ratios and regulatory changes, Humana remains focused on achieving long-term financial targets.
The company's commitment to operational excellence, membership growth, and pricing actions positions it for sustained success.
Strategic partnerships and risk management efforts showcase Humana's resilience and adaptability in a dynamic healthcare landscape.

Humana faces challenges from rising costs but eyes long-term growth

Humana's Q4 2023 earnings call highlighted challenges from increased medical costs and utilization trends impacting financial performance and outlook.
Despite disappointments in short-term results, the company remains confident in the long-term attractiveness of the Medicare Advantage sector.
Strategic efforts to restore margins, address utilization drivers, and engage with providers reflect a proactive approach to managing industry dynamics.
Balancing profitability with membership growth through benefit adjustments and pricing actions is crucial for Humana's sustainable financial performance.

Humana reports solid Q1 performance, eyes margin recovery in 2025

Humana's Q1 2024 earnings call highlighted a strong start to the year, challenges in the industry for 2025, and a focus on margin recovery and growth opportunities. The company remains confident in its outlook, emphasizing pricing discipline and maintaining a strong value proposition in the market.

Humana surpasses Q2 expectations, addresses cost pressures for growth

Humana's Q2 2024 performance exceeded expectations, driven by strong Medicare business and growth in Medicaid and primary care segments.
Challenges such as medical cost pressures were addressed through mitigation measures, while opportunities lie in strategic initiatives and long-term planning.
The company's focus on value, disciplined cost management, and operational efficiency position it well for sustained growth and value creation.

Humana surpasses Q3 expectations, eyes growth through efficiency and investments

Humana's Q3 performance exceeded expectations, with a focus on balancing earnings and investments. The company is strategically positioned to drive growth through membership expansion and operational efficiency. Challenges include managing costs and understanding market dynamics, with opportunities in improving Stars ratings and expanding senior care services.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

VANCOUVER, Wash.--(BUSINESS WIRE)--Vancouver Clinic and Humana Introduce New Primary Care Practice Designed to Enhance Medicare Advantage Experience

Vancouver Clinic and Humana Introduce New Primary Care Practice Designed to Enhance Medicare Advantage Experience

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, will make a presentation to investors at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference: A View from the Top on Thursday, January 6, 2022 at 1:00 p.m. Eastern time. Senior management is also scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, at 3:45 p.m. Eastern time. A live audio webcas

Humana Inc. to Present at Upcoming Industry Conferences

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and The Humana Foundation offer support to those affected by tornados

Humana and The Humana Foundation Offer Support to Those Affected by Tornados

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Military earns URAC accreditations in Case and Disease Management.

Humana Military Earns URAC Accreditations in Case and Disease Management

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Foundation Names Tiffany Benjamin As Chief Executive Officer

Humana Foundation Names Tiffany Benjamin As Chief Executive Officer

Activision Blizzard

Deere & Company

Lowe's

Mastercard

Monolithic Power Systems

Morgan Stanley

MSCI

NVIDIA

Charles Schwab

SS&C Technologies Hlds

T. Rowe Price Group

UnitedHealth Group

Visa

West Pharmaceutical Services

I present my top 15 high-growth dividend stocks to consider during the month of December.

Top 15 High Growth Dividend Stocks For December 2021

Humana (HUM) reported earnings 30 days ago. What's next for the stock?

Humana (HUM) Down 7.1% Since Last Earnings Report: Can It Rebound?

Humana (HUM) forges an alliance with the Loudoun Medical Group to boost its Medicare Advantage portfolio.

Humana (HUM) Ties Up to Enhance Medicare Advantage Business

Ginkgo Bioworks Holdings

Viking Global leader Andreas Halvorsen (Trades, Portfolio) disclosed his portfolio for the third quarter in November.

Andreas Halvorsen Dives Into Ginkgo Bioworks, Adds to Humana

LEESBURG, Va.--(BUSINESS WIRE)--Loudoun Medical Group joins Humana Medicare Advantage network.

Loudoun Medical Group Joins Humana Medicare Advantage Network

Humana (HUM) expands the value-based agreement with Hutchinson Clinic in a bid to provide enhanced healthcare services to its MA members in central Kansas.

Humana (HUM) to Provide Value-Based Care in Central Kansas

Humana (HUM) expands value-based agreement with Allina Health, which is aimed at offering enhanced outcomes for HUM's MA members in Minnesota.

Humana (HUM) Ties Up With Allina Health to Boost Value-Based Care

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at the BofA Home Care Conference on Monday, December 6, 2021, at 1:10 p.m. Eastern time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to allow time to run a system tes

Humana Inc. to Present at the Inaugural BofA Securities Home Care Conference

HUTCHINSON, Kan.--(BUSINESS WIRE)--Humana expands value-based agreement with Hutchinson Clinic to increase Medicare Advantage access in central Kansas

Humana Expands Value-Based Agreement with Hutchinson Clinic to Increase Medicare Advantage Access in Central Kansas

MINNEAPOLIS--(BUSINESS WIRE)--Humana announces value-based agreement with Allina Health in Minnesota

Humana Announces Value-Based Agreement with Allina Health in Minnesota

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana's Preferred Medicare Part D Network to include more than 11,000 retail pharmacy locations in 2022.

Humana's Preferred Medicare Part D Network to Include More Than 11,000 Retail Pharmacy Locations in 2022

LOUISVILLE, Ky.--(BUSINESS WIRE)--New report finds value-based care agreements benefited Humana medicare advantage members with reduced hospitalizations, more preventive care

New Report Finds Value-Based Care Agreements Benefited Humana Medicare Advantage Members with Reduced Hospitalizations, More Preventive Care During COVID-19 Pandemic

COLLEGE STATION, Texas--(BUSINESS WIRE)--Texas A&M's Mays Business School and Humana announce winners of fifth annual Healthcare Analytics Case Competition.

Texas A&M's Mays Business School and Humana Announce Winners of Fifth Annual Healthcare Analytics Case Competition

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana earns designation as #1 large company Military Friendly Employer.

Humana Earns Designation as #1 Large Company Military Friendly Employer

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Veteran population is the latest addition to its Bold Goal communities. The Bold Goal is Humana's ambitious population health strategy to improve the health of the communities it serves. Since the 2015 unveiling of its Bold Goal, Humana has focused on addressing the impact that social determinants and health-related social needs such as food insecurity, social isolation and loneliness, transportation and housing

Humana Announces Additional Bold Goal Community for Veterans Population

Applied Materials

Amphenol

Lam Research

Texas Instruments

I present my top 15 dividend growth stocks to consider during the month of November. Last month's list returned 8.52% in October, outpacing SPY by 1.5%.

Top 15 Dividend Growth Stocks For November 2021

MIAMI--(BUSINESS WIRE)--It's the fifth time and fourth consecutive year that CarePlus Health Plans, Inc.'s Medicare Advantage HMO plan in Florida has achieved the highest possible quality rating, 5 out of 5 stars, from the Centers for Medicare & Medicaid Services (CMS). CarePlus is a subsidiary of Humana Inc. (NYSE: HUM). The 5-star rating recognizes the continued emphasis the company has placed on creating the highest possible quality healthcare and customer service experience for its memb

For Fourth Consecutive Year, CarePlus Health Plans Attains Medicare's Highest 5 out of 5-Star Rating for 2022

On Wednesday, Humana Inc. (NYSE:HUM) shares edged slightly lower after reporting its fiscal third-quarter results. The company announced its most recent quarterly results before markets opened, beating analysts expectations on earnings.

Should you buy Humana shares after posting mixed FQ3 results?

Humana Inc. (HUM) CEO Bruce Broussard on Q3 2021 results - Earnings Call Transcript

Humana's (HUM) Q3 results reflect a better revenue stream and strength in its Retail and Healthcare Services segments.

News for Humana Stock (HUM)